These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34363617)
21. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial. Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236 [TBL] [Abstract][Full Text] [Related]
22. Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double-blind clinical trial. Ernst AA; Weiss SJ; Park S; Takakuwa KM; Diercks DB Ann Emerg Med; 2000 Aug; 36(2):89-94. PubMed ID: 10918098 [TBL] [Abstract][Full Text] [Related]
23. Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery. Yang Y; Wu J; Li H; Ye S; Xu X; Cheng L; Zhu L; Peng Z; Feng Z BMC Anesthesiol; 2018 Apr; 18(1):37. PubMed ID: 29636011 [TBL] [Abstract][Full Text] [Related]
24. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. Gilbert CJ; Ohly KV; Rosner G; Peters WP Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039 [TBL] [Abstract][Full Text] [Related]
25. An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients. Chae D; Park K J Pharmacokinet Pharmacodyn; 2018 Oct; 45(5):721-731. PubMed ID: 30043250 [TBL] [Abstract][Full Text] [Related]
26. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Connor KM; Shapiro RE; Diener HC; Lucas S; Kost J; Fan X; Fei K; Assaid C; Lines C; Ho TW Neurology; 2009 Sep; 73(12):970-7. PubMed ID: 19770473 [TBL] [Abstract][Full Text] [Related]
27. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study. Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007 [TBL] [Abstract][Full Text] [Related]
28. Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study. Alpuente A; Torre-Sune A; Caronna E; Gine-Cipres E; Torres-Ferrús M; Pozo-Rosich P Cephalalgia; 2023 Aug; 43(8):3331024231177636. PubMed ID: 37555331 [TBL] [Abstract][Full Text] [Related]
29. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Carleton SC; Shesser RF; Pietrzak MP; Chudnofsky CR; Starkman S; Morris DL; Johnson G; Rhee KJ; Barton CW; Chelly JE; Rosenberg J; Van Valen MK Ann Emerg Med; 1998 Aug; 32(2):129-38. PubMed ID: 9701293 [TBL] [Abstract][Full Text] [Related]
30. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Brousseau DC; Duffy SJ; Anderson AC; Linakis JG Ann Emerg Med; 2004 Feb; 43(2):256-62. PubMed ID: 14747817 [TBL] [Abstract][Full Text] [Related]
31. IV prochlorperazine + diphenhydramine improved migraine pain relief more than IV hydromorphone in the ED. Chessman AW Ann Intern Med; 2018 Mar; 168(6):JC28. PubMed ID: 29554666 [No Abstract] [Full Text] [Related]
32. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Trottier ED; Bailey B; Lucas N; Lortie A Am J Emerg Med; 2012 Mar; 30(3):456-63. PubMed ID: 21296523 [TBL] [Abstract][Full Text] [Related]
33. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Jones J; Pack S; Chun E Am J Emerg Med; 1996 May; 14(3):262-4. PubMed ID: 8639197 [TBL] [Abstract][Full Text] [Related]
34. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis. Cady R Headache; 2002 Jan; 42 Suppl 1():26-31. PubMed ID: 11966861 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Standard Combination Therapy in Pediatric Migraine. Kannikeswaran N; Desai L; Farooqi A; Sivaswamy L Pediatr Neurol; 2021 Mar; 116():68-73. PubMed ID: 33493999 [TBL] [Abstract][Full Text] [Related]
36. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Coppola M; Yealy DM; Leibold RA Ann Emerg Med; 1995 Nov; 26(5):541-6. PubMed ID: 7486359 [TBL] [Abstract][Full Text] [Related]
37. Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial. Collins RW; Jones JB; Walthall JD; Chisholm CD; Giles BK; Brizendine EJ; Cordell WH Ann Emerg Med; 2001 Nov; 38(5):491-6. PubMed ID: 11679859 [TBL] [Abstract][Full Text] [Related]
38. Variations among emergency departments in the treatment of benign headache. Vinson DR; Hurtado TR; Vandenberg JT; Banwart L Ann Emerg Med; 2003 Jan; 41(1):90-7. PubMed ID: 12514688 [TBL] [Abstract][Full Text] [Related]
39. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea. Schulman EA Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837 [TBL] [Abstract][Full Text] [Related]
40. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine. Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]